Sensitivity and Specificity
"Sensitivity and Specificity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Descriptor ID |
D012680
|
MeSH Number(s) |
E05.318.740.872 E05.318.780.800 G17.800 N05.715.360.750.725 N05.715.360.780.700 N06.850.520.445.800 N06.850.520.830.872
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sensitivity and Specificity".
Below are MeSH descriptors whose meaning is more specific than "Sensitivity and Specificity".
This graph shows the total number of publications written about "Sensitivity and Specificity" by people in this website by year, and whether "Sensitivity and Specificity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 35 | 35 |
1995 | 0 | 36 | 36 |
1996 | 0 | 55 | 55 |
1997 | 0 | 56 | 56 |
1998 | 0 | 51 | 51 |
1999 | 0 | 67 | 67 |
2000 | 1 | 66 | 67 |
2001 | 0 | 62 | 62 |
2002 | 0 | 88 | 88 |
2003 | 0 | 138 | 138 |
2004 | 0 | 146 | 146 |
2005 | 0 | 153 | 153 |
2006 | 0 | 147 | 147 |
2007 | 0 | 162 | 162 |
2008 | 0 | 185 | 185 |
2009 | 0 | 147 | 147 |
2010 | 1 | 125 | 126 |
2011 | 1 | 147 | 148 |
2012 | 0 | 135 | 135 |
2013 | 0 | 118 | 118 |
2014 | 0 | 140 | 140 |
2015 | 0 | 129 | 129 |
2016 | 0 | 120 | 120 |
2017 | 0 | 106 | 106 |
2018 | 0 | 77 | 77 |
2019 | 0 | 79 | 79 |
2020 | 0 | 67 | 67 |
2021 | 0 | 53 | 53 |
2022 | 0 | 30 | 30 |
2023 | 0 | 13 | 13 |
2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sensitivity and Specificity" by people in Profiles.
-
False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clin Infect Dis. 2024 03 20; 78(3):674-680.
-
The infected diabetic foot: Modulation of traditional biomarkers for osteomyelitis diagnosis in the setting of diabetic foot infection and renal impairment. Int Wound J. 2024 Mar; 21(3):e14770.
-
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233.
-
Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers. Anal Biochem. 2024 May; 688:115480.
-
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer. 2024 Mar; 130(5):861-868.
-
A rapid, low-cost, and highly sensitive SARS-CoV-2 diagnostic based on whole-genome sequencing. PLoS One. 2023; 18(11):e0294283.
-
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
-
The infected diabetes-related foot: Comparison of erythrocyte sedementation rate/albumin and C-reactive protein/albumin ratios with erythrocyte sedimentation rate and C-reactive protein to differentiate bone and soft tissue infections. Wound Repair Regen. 2023 Nov-Dec; 31(6):738-744.
-
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions. Cancer Med. 2023 11; 12(21):20626-20638.
-
Performance of the Spot Vision Screener in children with Down syndrome and other special needs. J AAPOS. 2023 10; 27(5):274.e1-274.e7.